<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02619396</url>
  </required_header>
  <id_info>
    <org_study_id>11536-SPON</org_study_id>
    <nct_id>NCT02619396</nct_id>
  </id_info>
  <brief_title>RF Power, LSI and Oesophageal Temperature Alerts During AF Ablation (PiLOT-AF Study)</brief_title>
  <acronym>PiLOT-AF</acronym>
  <official_title>Radiofrequency Power, Lesion Size Index and Oesophageal Temperature Alerts During Atrial Fibrillation Ablation: A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oxford University Hospitals NHS Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oxford University Hospitals NHS Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Atrial fibrillation (AF) is a very common abnormal heart rhythm, triggered by rapid
      electrical activity originating from the pulmonary veins (PVs) that drain blood from the
      lungs back to the left atrium (LA). Ablation of the junction between the PVs and the LA,
      electrically isolating the veins from the heart, is the key to prevent AF.

      When using radiofrequency energy (RF), transmural lesions are required to achieve permanent
      pulmonary vein isolation (PVI). New technologies are currently available to predict the
      ablation lesion depth and to guide the duration of each application. However, deeper lesions
      mean a higher risk of overheating and damage of adjacent structures such as the esophagus
      that lies against the back wall of the LA. In order to minimize this risk, the investigators
      continuously monitor the temperature inside the esophagus during the procedure through a
      probe placed in the esophagus and they promptly terminate energy delivery in case of any
      esophageal temperature rises more than 39°C.

      To date, it is not known if a low power for a longer time is better than a high power for a
      shorter time when ablating on the LA posterior wall in order to create permanent scars
      without heating the esophagus.

      Therefore, the investigators plan to compare the incidence of esophageal temperature alerts
      and the success of the procedure with four different energy settings during ablation on the
      LA posterior wall.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The PiLOT-AF study is a prospective single-centre randomized observational study aiming at
      comparing different radiofrequency energy (RF) settings during atrial fibrillation (AF)
      ablation on the left atrial (LA) posterior wall, in terms of esophageal heating, acute and
      long-term procedure success and procedural complications.

      Patients scheduled for their first RF ablation, because of a history of symptomatic and
      drug-refractory paroxysmal or persistent AF, will be considered for inclusion in the study.

      Potential subjects will initially be approached 4-6 weeks before their ablation procedure, in
      order to give them enough time to consider the information, to ask questions to the
      investigators, their family doctor or other independent parties to decide whether they wish
      to participate in the study or not.

      For those interested in participation, a baseline assessment will be arranged to coincide
      with their standard pre-admission visit, for informed consent, screening and eligibility
      assessment and randomization.

      All AF ablation procedures will be performed in a standard fashion, under general anaesthesia
      and with continuous esophageal temperature monitoring using a sinusoidal multi-sensor
      esophageal temperature probe (CIRCAtemp). After LA geometry reconstruction using
      3-dimensional electroanatomical mapping EnSite Velocity and a multipolar circular mapping
      catheter St Jude Medical Optima, the ablation catheter Endosense Tacticath through a
      deflectable sheath St Medical Agilis will be used for Pulmonary Vein Isolation (PVI).
      Standardized RF settings will be used during ablation on the LA anterior wall as current
      practice in our centre. Different RF settings will be used on the LA posterior wall,
      according to randomization group. Moreover target values will be chosen for Lesion Size Index
      (LSI), a parameter useful to predict the lesion depth, during ablation on LA posterior wall.
      The duration of RF delivery on the LA posterior wall will be dictated by achievement of the
      target LSI or esophageal temperature rise &gt; 39◦C during ablation. PVI will be achieved and
      confirmed after 30 minutes waiting time. In case of acute PV reconnection, ablation at sites
      of breakthrough signals will be performed in order to achieve durable PVI. The occurrence of
      acute PV reconnection (PVR) with sites of breakthrough signals on the LA posterior wall will
      be recorded for each procedure. The total procedure and RF ablation times will be also
      collected.

      After the ablation, before discharge the symptoms status and heart rhythm will be assessed
      and the patient will be instructed to commence a symptoms diary. Telephone follow-ups will be
      then performed at 3 and 6 months to assess current symptom status. Standard care follow-up
      Arrhythmia Clinic visits will be also performed 3-4 months after the ablation procedure. Ad
      hoc visits and/or additional investigations as prolonged electrocardiogram (ECG) monitoring
      will also take place, dictated by arrhythmia symptoms and assessment for potential adverse
      events related to the procedure, in accordance with standard practice.

      The end of the study for each patient will be the date of the 6 months telephone follow-up.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Actual">March 11, 2017</completion_date>
  <primary_completion_date type="Actual">March 11, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of Oesophageal Temperature Alerts During Radiofrequency Energy (RF) Ablation on the Left Atrial (LA) Posterior Wall</measure>
    <time_frame>1 day</time_frame>
    <description>Number of patients with luminal oesophageal temperature rises &gt; 39◦C during radiofrequency (RF) ablation on the left atrial (LA) posterior wall</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Oesophageal Temperature Alerts Per Patient</measure>
    <time_frame>1 day</time_frame>
    <description>Number of oesophageal temperature alerts per patient</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of First-pass Pulmonary Vein Isolation (PVI)</measure>
    <time_frame>1 day</time_frame>
    <description>Rate of Pulmonary Veins (PVs) isolated after completion of first Pulmonary Vein Encirclement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of Acute Pulmonary Vein Reconnection (PVR)</measure>
    <time_frame>1 day</time_frame>
    <description>Number of pulmonary veins acutely reconnected after catheter ablation and isolation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Procedure Time</measure>
    <time_frame>1 day</time_frame>
    <description>Total duration of the procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Radiofrequency Energy (RF) Time for Pulmonary Vein Isolation (PVI)</measure>
    <time_frame>1 day</time_frame>
    <description>Total duration of radiofrequency energy required to achieve electrical isolation of the pulmonary veins</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Freedom From Atrial Fibrillation</measure>
    <time_frame>6 months after the procedure</time_frame>
    <description>Absence of symptoms suggestive of atrial fibrillation and no documentation of atrial fibrillation during the follow-up period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Esophageal Symptoms After the Atrial Fibrillation (AF) Ablation</measure>
    <time_frame>6 months after the procedure</time_frame>
    <description>Difficult or painful swallowing, heartburn, acid reflux, sore throat, hoarseness, cough, nausea, vomiting, non-cardiac chest pain</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Procedural Complications</measure>
    <time_frame>1 day</time_frame>
    <description>Pericardial effusion, transient ischemic attack/stroke, phrenic nerve injury, pulmonary vein stenosis, open-heart surgery, death</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>Group &quot;20 W / LSI 4&quot;</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients elected to atrial fibrillation (AF) ablation and randomized to Combination 1 of radiofrequency (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior wall</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group &quot;40 W / LSI 4&quot;</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients elected to atrial fibrillation (AF) ablation and randomized to Combination 2 of radiofrequency (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior wall</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group &quot;20 W / LSI 5&quot;</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients elected to atrial fibrillation (AF) ablation and randomized to Combination 3 of radiofrequency (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior wall</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group &quot;40 W / LSI 5&quot;</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients elected to atrial fibrillation (AF) ablation and randomized to Combination 4 of radiofrequency (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior wall</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Combination 1 of radiofrequency (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior wall</intervention_name>
    <description>20 W RF power and target LSI = 4 on LA posterior wall</description>
    <arm_group_label>Group &quot;20 W / LSI 4&quot;</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Combination 2 of radiofrequency (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior wall</intervention_name>
    <description>40 W RF power and target LSI = 4 on LA posterior wall</description>
    <arm_group_label>Group &quot;40 W / LSI 4&quot;</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Combination 3 of radiofrequency (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior wall</intervention_name>
    <description>20 W RF power and target LSI = 5 on LA posterior wall</description>
    <arm_group_label>Group &quot;20 W / LSI 5&quot;</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Combination 4 of radiofrequency (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior wall</intervention_name>
    <description>40 W RF power and target LSI = 5 on LA posterior wall</description>
    <arm_group_label>Group &quot;40 W / LSI 5&quot;</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  male or female, aged 18 to 80 years;

          -  willing and able to give informed consent for participation in the study;

          -  history of symptomatic and drug-refractory atrial fibrillation;

          -  planned atrial fibrillation (AF) ablation on a clinical basis.

        Exclusion Criteria:

          -  previous AF ablation;

          -  pregnancy, trying for a baby or breast feeding;

          -  oesophageal obstruction (mass, stricture), diverticulum or varices,
             tracheo-oesophageal fistula or any other oesophageal conditions prohibiting the use of
             oesophageal temperature probe for continuous luminal temperature monitoring;

          -  any other significant disease or disorder which, in the opinion of the investigator,
             may either put the participants at risk because of participation in the study, or may
             influence the result of the study, or the participant's ability to participate in the
             study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tim R Betts, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oxford University Hospitals NHS Trust</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>John Radcliffe Hospital</name>
      <address>
        <city>Oxford</city>
        <zip>OX3 9DU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>Petersen HH, Chen X, Pietersen A, Svendsen JH, Haunsø S. Tissue temperatures and lesion size during irrigated tip catheter radiofrequency ablation: an in vitro comparison of temperature-controlled irrigated tip ablation, power-controlled irrigated tip ablation, and standard temperature-controlled ablation. Pacing Clin Electrophysiol. 2000 Jan;23(1):8-17.</citation>
    <PMID>10666748</PMID>
  </reference>
  <reference>
    <citation>Haines DE. Determinants of lesion size during radiofrequency catheter ablation: the role of electrode-tissue contact pressure and duration of energy delivery. Journal of Cardiovascular Electrophysiology. 2008;2(6):509-15.</citation>
  </reference>
  <reference>
    <citation>Kautzner J, Neuzil P, Peickl P. Contact force, FTI and Lesion continuity are critical to improve durable PV isolation: EFFICAS 2 results. Heart Rhythm. 2012;9(5S):1-564</citation>
  </reference>
  <reference>
    <citation>Cummings JE, Schweikert RA, Saliba WI, Burkhardt JD, Brachmann J, Gunther J, Schibgilla V, Verma A, Dery M, Drago JL, Kilicaslan F, Natale A. Assessment of temperature, proximity, and course of the esophagus during radiofrequency ablation within the left atrium. Circulation. 2005 Jul 26;112(4):459-64. Epub 2005 Jul 18.</citation>
    <PMID>16027254</PMID>
  </reference>
  <reference>
    <citation>Singh SM, d'Avila A, Doshi SK, Brugge WR, Bedford RA, Mela T, Ruskin JN, Reddy VY. Esophageal injury and temperature monitoring during atrial fibrillation ablation. Circ Arrhythm Electrophysiol. 2008 Aug;1(3):162-8. doi: 10.1161/CIRCEP.107.789552. Erratum in: Circ Arrhythm Electrophysiol. 2012 Feb 1;5(1):e30.</citation>
    <PMID>19808410</PMID>
  </reference>
  <reference>
    <citation>Kowalski M, Grimes MM, Perez FJ, Kenigsberg DN, Koneru J, Kasirajan V, Wood MA, Ellenbogen KA. Histopathologic characterization of chronic radiofrequency ablation lesions for pulmonary vein isolation. J Am Coll Cardiol. 2012 Mar 6;59(10):930-8. doi: 10.1016/j.jacc.2011.09.076.</citation>
    <PMID>22381429</PMID>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>October 26, 2015</study_first_submitted>
  <study_first_submitted_qc>November 30, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 2, 2015</study_first_posted>
  <results_first_submitted>March 6, 2020</results_first_submitted>
  <results_first_submitted_qc>July 7, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">July 8, 2020</results_first_posted>
  <last_update_submitted>July 7, 2020</last_update_submitted>
  <last_update_submitted_qc>July 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oxford University Hospitals NHS Trust</investigator_affiliation>
    <investigator_full_name>Dr Tim Betts MD MBChB FRCP</investigator_full_name>
    <investigator_title>Consultant Cardiologist and Electrophysiologist</investigator_title>
  </responsible_party>
  <keyword>radiofrequency power</keyword>
  <keyword>lesion size index</keyword>
  <keyword>esophageal temperature alerts</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 10, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/96/NCT02619396/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Group &quot;20 W / LSI 4&quot;</title>
          <description>Patients elected to AF ablation and randomized to Combination 1 of RF power and LSI on LA posterior wall
Combination 1 of RF power and LSI on LA posterior wall: 20 W RF power and target LSI = 4 on LA posterior wall</description>
        </group>
        <group group_id="P2">
          <title>Group &quot;40 W / LSI 4&quot;</title>
          <description>Patients elected to AF ablation and randomized to Combination 2 of RF power and LSI on LA posterior wall
Combination 2 of RF power and LSI on LA posterior wall: 40 W RF power and target LSI = 4 on LA posterior wall</description>
        </group>
        <group group_id="P3">
          <title>Group &quot;20 W / LSI 5&quot;</title>
          <description>Patients elected to AF ablation and randomized to Combination 3 of RF power and LSI on LA posterior wall
Combination 3 of RF power and LSI on LA posterior wall: 20 W RF power and target LSI = 5 on LA posterior wall</description>
        </group>
        <group group_id="P4">
          <title>Group &quot;40 W / LSI 5&quot;</title>
          <description>Patients elected to AF ablation and randomized to Combination 4 of RF power and LSI on LA posterior wall
Combination 4 of RF power and LSI on LA posterior wall: 40 W RF power and target LSI = 5 on LA posterior wall</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
                <participants group_id="P3" count="20"/>
                <participants group_id="P4" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
                <participants group_id="P3" count="20"/>
                <participants group_id="P4" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Group &quot;20 W / LSI 4&quot;</title>
          <description>Patients elected to AF ablation and randomized to Combination 1 of RF power and Lesion Size Index (LSI) on LA posterior wall: 20 W RF power and target LSI = 4 on LA posterior wall</description>
        </group>
        <group group_id="B2">
          <title>Group &quot;40 W / LSI 4&quot;</title>
          <description>Patients elected to AF ablation and randomized to Combination 2 of RF power and Lesion Size Index (LSI) on LA posterior wall: 40 W RF power and target LSI = 4 on LA posterior wall</description>
        </group>
        <group group_id="B3">
          <title>Group &quot;20 W / LSI 5&quot;</title>
          <description>Patients elected to AF ablation and randomized to Combination 3 of RF power and Lesion Size Index (LSI) on LA posterior wall: 20 W RF power and target LSI = 5 on LA posterior wall</description>
        </group>
        <group group_id="B4">
          <title>Group &quot;40 W / LSI 5&quot;</title>
          <description>Patients elected to AF ablation and randomized to Combination 4 of RF power and Lesion Size Index (LSI) on LA posterior wall: 40 W RF power and target LSI = 5 on LA posterior wall</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
            <count group_id="B2" value="20"/>
            <count group_id="B3" value="20"/>
            <count group_id="B4" value="20"/>
            <count group_id="B5" value="80"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                    <count group_id="B2" value="20"/>
                    <count group_id="B3" value="20"/>
                    <count group_id="B4" value="20"/>
                    <count group_id="B5" value="80"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="58.9" spread="9.2"/>
                    <measurement group_id="B2" value="60.1" spread="9.4"/>
                    <measurement group_id="B3" value="55.7" spread="10"/>
                    <measurement group_id="B4" value="61.3" spread="9.6"/>
                    <measurement group_id="B5" value="59.0" spread="9.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                    <count group_id="B2" value="20"/>
                    <count group_id="B3" value="20"/>
                    <count group_id="B4" value="20"/>
                    <count group_id="B5" value="80"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="6"/>
                    <measurement group_id="B5" value="21"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="14"/>
                    <measurement group_id="B4" value="14"/>
                    <measurement group_id="B5" value="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                    <count group_id="B4" value="0"/>
                    <count group_id="B5" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United Kingdom</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                    <count group_id="B2" value="20"/>
                    <count group_id="B3" value="20"/>
                    <count group_id="B4" value="20"/>
                    <count group_id="B5" value="80"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="20"/>
                    <measurement group_id="B4" value="20"/>
                    <measurement group_id="B5" value="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Paroxysmal atrial fibrillation (AF)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                    <count group_id="B2" value="20"/>
                    <count group_id="B3" value="20"/>
                    <count group_id="B4" value="20"/>
                    <count group_id="B5" value="80"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="8"/>
                    <measurement group_id="B5" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Atrial fibrillation (AF) history duration (months)</title>
          <units>months</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                    <count group_id="B2" value="20"/>
                    <count group_id="B3" value="20"/>
                    <count group_id="B4" value="20"/>
                    <count group_id="B5" value="80"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24" lower_limit="17" upper_limit="44"/>
                    <measurement group_id="B2" value="27" lower_limit="18" upper_limit="48"/>
                    <measurement group_id="B3" value="20" lower_limit="17" upper_limit="44"/>
                    <measurement group_id="B4" value="24" lower_limit="21" upper_limit="45"/>
                    <measurement group_id="B5" value="24" lower_limit="17" upper_limit="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index (BMI)</title>
          <units>BMI unit = kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                    <count group_id="B2" value="20"/>
                    <count group_id="B3" value="20"/>
                    <count group_id="B4" value="20"/>
                    <count group_id="B5" value="80"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30.8" spread="4.6"/>
                    <measurement group_id="B2" value="27.3" spread="5"/>
                    <measurement group_id="B3" value="28.2" spread="4.85"/>
                    <measurement group_id="B4" value="28.8" spread="4.9"/>
                    <measurement group_id="B5" value="29.2" spread="6.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Left atrial (LA) size</title>
          <units>diameter (mm)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                    <count group_id="B2" value="20"/>
                    <count group_id="B3" value="20"/>
                    <count group_id="B4" value="20"/>
                    <count group_id="B5" value="80"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="43" spread="6"/>
                    <measurement group_id="B2" value="41.4" spread="6.5"/>
                    <measurement group_id="B3" value="42.4" spread="7.7"/>
                    <measurement group_id="B4" value="43.7" spread="9.3"/>
                    <measurement group_id="B5" value="42.8" spread="7.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Left ventricular (LV) function</title>
          <units>LVEF (%)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                    <count group_id="B2" value="20"/>
                    <count group_id="B3" value="20"/>
                    <count group_id="B4" value="20"/>
                    <count group_id="B5" value="80"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60" spread="11.5"/>
                    <measurement group_id="B2" value="60" spread="9.2"/>
                    <measurement group_id="B3" value="60" spread="10.2"/>
                    <measurement group_id="B4" value="57.9" spread="6.4"/>
                    <measurement group_id="B5" value="59.4" spread="9.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Rate of Oesophageal Temperature Alerts During Radiofrequency Energy (RF) Ablation on the Left Atrial (LA) Posterior Wall</title>
        <description>Number of patients with luminal oesophageal temperature rises &gt; 39◦C during radiofrequency (RF) ablation on the left atrial (LA) posterior wall</description>
        <time_frame>1 day</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group &quot;20 W / LSI 4&quot;</title>
            <description>Patients elected to atrial fibrillation (AF) ablation and randomized to Combination 1 of radiofrequency energy (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior wall
Combination 1 of radiofrequency energy (RF) power and lesion Size Index (LSI) on LA posterior wall: 20 W RF power and target LSI = 4 on LA posterior wall</description>
          </group>
          <group group_id="O2">
            <title>Group &quot;40 W / LSI 4&quot;</title>
            <description>Patients elected to atrial fibrillation (AF) ablation and randomized to Combination 2 of radiofrequency energy (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior wall
Combination 2 of radiofrequency energy (RF) power and lesion Size Index (LSI) on LA posterior wall: 40 W RF power and target LSI = 4 on LA posterior wall</description>
          </group>
          <group group_id="O3">
            <title>Group &quot;20 W / LSI 5&quot;</title>
            <description>Patients elected to atrial fibrillation (AF) ablation and randomized to Combination 3 of radiofrequency energy (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior wall
Combination 3 of radiofrequency energy (RF) power and lesion Size Index (LSI) on LA posterior wall: 20 W RF power and target LSI = 5 on LA posterior wall</description>
          </group>
          <group group_id="O4">
            <title>Group &quot;40 W / LSI 5&quot;</title>
            <description>Patients elected to atrial fibrillation (AF) ablation and randomized to Combination 4 of radiofrequency energy (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior wall
Combination 4 of radiofrequency energy (RF) power and lesion Size Index (LSI) on LA posterior wall: 40 W RF power and target LSI = 5 on LA posterior wall</description>
          </group>
        </group_list>
        <measure>
          <title>Rate of Oesophageal Temperature Alerts During Radiofrequency Energy (RF) Ablation on the Left Atrial (LA) Posterior Wall</title>
          <description>Number of patients with luminal oesophageal temperature rises &gt; 39◦C during radiofrequency (RF) ablation on the left atrial (LA) posterior wall</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="18"/>
                    <measurement group_id="O3" value="19"/>
                    <measurement group_id="O4" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Oesophageal Temperature Alerts Per Patient</title>
        <description>Number of oesophageal temperature alerts per patient</description>
        <time_frame>1 day</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group &quot;20 W / LSI 4&quot;</title>
            <description>Patients elected to atrial fibrillation (AF) ablation and randomized to Combination 1 of radiofrequency energy (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior wall
Combination 1 of radiofrequency energy (RF) power and lesion Size Index (LSI) on LA posterior wall: 20 W RF power and target LSI = 4 on LA posterior wall</description>
          </group>
          <group group_id="O2">
            <title>Group &quot;40 W / LSI 4&quot;</title>
            <description>Patients elected to atrial fibrillation (AF) ablation and randomized to Combination 2 of radiofrequency energy (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior wall
Combination 2 of radiofrequency energy (RF) power and lesion Size Index (LSI) on LA posterior wall: 40 W RF power and target LSI = 4 on LA posterior wall</description>
          </group>
          <group group_id="O3">
            <title>Group &quot;20 W / LSI 5&quot;</title>
            <description>Patients elected to atrial fibrillation (AF) ablation and randomized to Combination 3 of radiofrequency energy (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior wall
Combination 3 of radiofrequency energy (RF) power and lesion Size Index (LSI) on LA posterior wall: 20 W RF power and target LSI = 5 on LA posterior wall</description>
          </group>
          <group group_id="O4">
            <title>Group &quot;40 W / LSI 5&quot;</title>
            <description>Patients elected to atrial fibrillation (AF) ablation and randomized to Combination 4 of radiofrequency energy (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior wall
Combination 4 of radiofrequency energy (RF) power and lesion Size Index (LSI) on LA posterior wall: 40 W RF power and target LSI = 5 on LA posterior wall</description>
          </group>
        </group_list>
        <measure>
          <title>Oesophageal Temperature Alerts Per Patient</title>
          <description>Number of oesophageal temperature alerts per patient</description>
          <units>oesophageal temperature alerts</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="2" upper_limit="8"/>
                    <measurement group_id="O2" value="4" lower_limit="2" upper_limit="6"/>
                    <measurement group_id="O3" value="7" lower_limit="5" upper_limit="10"/>
                    <measurement group_id="O4" value="4" lower_limit="2" upper_limit="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Rate of First-pass Pulmonary Vein Isolation (PVI)</title>
        <description>Rate of Pulmonary Veins (PVs) isolated after completion of first Pulmonary Vein Encirclement</description>
        <time_frame>1 day</time_frame>
        <population>80 pulmonary veins in each group (4 veins per patient, 20 patients)</population>
        <group_list>
          <group group_id="O1">
            <title>Group &quot;20 W / LSI 4&quot;</title>
            <description>Patients elected to atrial fibrillation (AF) ablation and randomized to Combination 1 of radiofrequency energy (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior wall
Combination 1 of radiofrequency energy (RF) power and lesion Size Index (LSI) on LA posterior wall: 20 W RF power and target LSI = 4 on LA posterior wall</description>
          </group>
          <group group_id="O2">
            <title>Group &quot;40 W / LSI 4&quot;</title>
            <description>Patients elected to atrial fibrillation (AF) ablation and randomized to Combination 2 of radiofrequency energy (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior wall
Combination 2 of radiofrequency energy (RF) power and lesion Size Index (LSI) on LA posterior wall: 40 W RF power and target LSI = 4 on LA posterior wall</description>
          </group>
          <group group_id="O3">
            <title>Group &quot;20 W / LSI 5&quot;</title>
            <description>Patients elected to atrial fibrillation (AF) ablation and randomized to Combination 3 of radiofrequency energy (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior wall
Combination 3 of radiofrequency energy (RF) power and lesion Size Index (LSI) on LA posterior wall: 20 W RF power and target LSI = 5 on LA posterior wall</description>
          </group>
          <group group_id="O4">
            <title>Group &quot;40 W / LSI 5&quot;</title>
            <description>Patients elected to atrial fibrillation (AF) ablation and randomized to Combination 4 of radiofrequency energy (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior wall
Combination 4 of radiofrequency energy (RF) power and lesion Size Index (LSI) on LA posterior wall: 40 W RF power and target LSI = 5 on LA posterior wall</description>
          </group>
        </group_list>
        <measure>
          <title>Rate of First-pass Pulmonary Vein Isolation (PVI)</title>
          <description>Rate of Pulmonary Veins (PVs) isolated after completion of first Pulmonary Vein Encirclement</description>
          <population>80 pulmonary veins in each group (4 veins per patient, 20 patients)</population>
          <units>pulmonary veins</units>
          <param>Number</param>
          <units_analyzed>number of pulmonary veins in each group</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="20"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>number of pulmonary veins in each group</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="80"/>
                <count group_id="O2" value="80"/>
                <count group_id="O3" value="80"/>
                <count group_id="O4" value="80"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59"/>
                    <measurement group_id="O2" value="59"/>
                    <measurement group_id="O3" value="38"/>
                    <measurement group_id="O4" value="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Rate of Acute Pulmonary Vein Reconnection (PVR)</title>
        <description>Number of pulmonary veins acutely reconnected after catheter ablation and isolation</description>
        <time_frame>1 day</time_frame>
        <population>80 pulmonary veins in each group (4 veins per patient, 20 patients)</population>
        <group_list>
          <group group_id="O1">
            <title>Group &quot;20 W / LSI 4&quot;</title>
            <description>Patients elected to atrial fibrillation (AF) ablation and randomized to Combination 1 of radiofrequency energy (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior wall
Combination 1 of radiofrequency energy (RF) power and lesion Size Index (LSI) on LA posterior wall: 20 W RF power and target LSI = 4 on LA posterior wall</description>
          </group>
          <group group_id="O2">
            <title>Group &quot;40 W / LSI 4&quot;</title>
            <description>Patients elected to atrial fibrillation (AF) ablation and randomized to Combination 2 of radiofrequency energy (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior wall
Combination 2 of radiofrequency energy (RF) power and lesion Size Index (LSI) on LA posterior wall: 40 W RF power and target LSI = 4 on LA posterior wall</description>
          </group>
          <group group_id="O3">
            <title>Group &quot;20 W / LSI 5&quot;</title>
            <description>Patients elected to atrial fibrillation (AF) ablation and randomized to Combination 3 of radiofrequency energy (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior wall
Combination 3of radiofrequency energy (RF) power and lesion Size Index (LSI) on LA posterior wall: 20 W RF power and target LSI = 5 on LA posterior wall</description>
          </group>
          <group group_id="O4">
            <title>Group &quot;40 W / LSI 5&quot;</title>
            <description>Patients elected to atrial fibrillation (AF) ablation and randomized to Combination 4 of radiofrequency energy (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior wall
Combination 4 of radiofrequency energy (RF) power and lesion Size Index (LSI) on LA posterior wall: 40 W RF power and target LSI = 5 on LA posterior wall</description>
          </group>
        </group_list>
        <measure>
          <title>Rate of Acute Pulmonary Vein Reconnection (PVR)</title>
          <description>Number of pulmonary veins acutely reconnected after catheter ablation and isolation</description>
          <population>80 pulmonary veins in each group (4 veins per patient, 20 patients)</population>
          <units>pulmonary veins</units>
          <param>Number</param>
          <units_analyzed>number of pulmonary veins in each group</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="20"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>number of pulmonary veins in each group</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="80"/>
                <count group_id="O2" value="80"/>
                <count group_id="O3" value="80"/>
                <count group_id="O4" value="80"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="17"/>
                    <measurement group_id="O4" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Procedure Time</title>
        <description>Total duration of the procedure</description>
        <time_frame>1 day</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group &quot;20 W / LSI 4&quot;</title>
            <description>Patients elected to atrial fibrillation (AF) ablation and randomized to Combination 1 of radiofrequency energy (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior wall
Combination 1 of radiofrequency energy (RF) power and lesion Size Index (LSI) on LA posterior wall: 20 W RF power and target LSI = 4 on LA posterior wall</description>
          </group>
          <group group_id="O2">
            <title>Group &quot;40 W / LSI 4&quot;</title>
            <description>Patients elected to atrial fibrillation (AF) ablation and randomized to Combination 2 of radiofrequency energy (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior wall
Combination 2 of radiofrequency energy (RF) power and lesion Size Index (LSI) on LA posterior wall: 40 W RF power and target LSI = 4 on LA posterior wall</description>
          </group>
          <group group_id="O3">
            <title>Group &quot;20 W / LSI 5&quot;</title>
            <description>Patients elected to atrial fibrillation (AF) ablation and randomized to Combination 3 of radiofrequency energy (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior wall
Combination 3 of radiofrequency energy (RF) power and lesion Size Index (LSI) on LA posterior wall: 20 W RF power and target LSI = 5 on LA posterior wall</description>
          </group>
          <group group_id="O4">
            <title>Group &quot;40 W / LSI 5&quot;</title>
            <description>Patients elected to atrial fibrillation (AF) ablation and randomized to Combination 4 of radiofrequency energy (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior wall
Combination 4 of radiofrequency energy (RF) power and lesion Size Index (LSI) on LA posterior wall: 40 W RF power and target LSI = 5 on LA posterior wall</description>
          </group>
        </group_list>
        <measure>
          <title>Total Procedure Time</title>
          <description>Total duration of the procedure</description>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="180" lower_limit="131.3" upper_limit="218"/>
                    <measurement group_id="O2" value="165" lower_limit="145" upper_limit="180"/>
                    <measurement group_id="O3" value="180" lower_limit="156.3" upper_limit="210"/>
                    <measurement group_id="O4" value="165" lower_limit="146.3" upper_limit="191.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Radiofrequency Energy (RF) Time for Pulmonary Vein Isolation (PVI)</title>
        <description>Total duration of radiofrequency energy required to achieve electrical isolation of the pulmonary veins</description>
        <time_frame>1 day</time_frame>
        <population>Patients/ablation procedures per group</population>
        <group_list>
          <group group_id="O1">
            <title>Group &quot;20 W / LSI 4&quot;</title>
            <description>Patients elected to atrial fibrillation (AF) ablation and randomized to Combination 1 of radiofrequency energy (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior wall
Combination 1 of radiofrequency energy (RF) power and lesion Size Index (LSI) on LA posterior wall: 20 W RF power and target LSI = 4 on LA posterior wall</description>
          </group>
          <group group_id="O2">
            <title>Group &quot;40 W / LSI 4&quot;</title>
            <description>Patients elected to atrial fibrillation (AF) ablation and randomized to Combination 2 of radiofrequency energy (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior wall
Combination 2 of radiofrequency energy (RF) power and lesion Size Index (LSI) on LA posterior wall: 40 W RF power and target LSI = 4 on LA posterior wall</description>
          </group>
          <group group_id="O3">
            <title>Group &quot;20 W / LSI 5&quot;</title>
            <description>Patients elected to atrial fibrillation (AF) ablation and randomized to Combination 3 of radiofrequency energy (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior wall
Combination 3 of radiofrequency energy (RF) power and lesion Size Index (LSI) on LA posterior wall: 20 W RF power and target LSI = 5 on LA posterior wall</description>
          </group>
          <group group_id="O4">
            <title>Group &quot;40 W / LSI 5&quot;</title>
            <description>Patients elected to atrial fibrillation (AF) ablation and randomized to Combination 4 of radiofrequency energy (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior wall
Combination 4 of radiofrequency energy (RF) power and lesion Size Index (LSI) on LA posterior wall: 40 W RF power and target LSI = 5 on LA posterior wall</description>
          </group>
        </group_list>
        <measure>
          <title>Total Radiofrequency Energy (RF) Time for Pulmonary Vein Isolation (PVI)</title>
          <description>Total duration of radiofrequency energy required to achieve electrical isolation of the pulmonary veins</description>
          <population>Patients/ablation procedures per group</population>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.4" lower_limit="25.2" upper_limit="40.1"/>
                    <measurement group_id="O2" value="23.8" lower_limit="16.9" upper_limit="34.7"/>
                    <measurement group_id="O3" value="38" lower_limit="28.4" upper_limit="46.3"/>
                    <measurement group_id="O4" value="22" lower_limit="18.7" upper_limit="33.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Freedom From Atrial Fibrillation</title>
        <description>Absence of symptoms suggestive of atrial fibrillation and no documentation of atrial fibrillation during the follow-up period</description>
        <time_frame>6 months after the procedure</time_frame>
        <population>Patients per group</population>
        <group_list>
          <group group_id="O1">
            <title>Group &quot;20 W / LSI 4&quot;</title>
            <description>Patients elected to atrial fibrillation (AF) ablation and randomized to Combination 1 of radiofrequency energy (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior wall
Combination 1 of radiofrequency energy (RF) power and lesion Size Index (LSI) on LA posterior wall: 20 W RF power and target LSI = 4 on LA posterior wall</description>
          </group>
          <group group_id="O2">
            <title>Group &quot;40 W / LSI 4&quot;</title>
            <description>Patients elected to atrial fibrillation (AF) ablation and randomized to Combination 2 of radiofrequency energy (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior wall
Combination 2 of radiofrequency energy (RF) power and lesion Size Index (LSI) on LA posterior wall: 40 W RF power and target LSI = 4 on LA posterior wall</description>
          </group>
          <group group_id="O3">
            <title>Group &quot;20 W / LSI 5&quot;</title>
            <description>Patients elected to atrial fibrillation (AF) ablation and randomized to Combination 3 of radiofrequency energy (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior wall
Combination 3 of radiofrequency energy (RF) power and lesion Size Index (LSI) on LA posterior wall: 20 W RF power and target LSI = 5 on LA posterior wall</description>
          </group>
          <group group_id="O4">
            <title>Group &quot;40 W / LSI 5&quot;</title>
            <description>Patients elected to atrial fibrillation (AF) ablation and randomized to Combination 4 of radiofrequency energy (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior wall
Combination 4 of radiofrequency energy (RF) power and lesion Size Index (LSI) on LA posterior wall: 40 W RF power and target LSI = 5 on LA posterior wall</description>
          </group>
        </group_list>
        <measure>
          <title>Freedom From Atrial Fibrillation</title>
          <description>Absence of symptoms suggestive of atrial fibrillation and no documentation of atrial fibrillation during the follow-up period</description>
          <population>Patients per group</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Esophageal Symptoms After the Atrial Fibrillation (AF) Ablation</title>
        <description>Difficult or painful swallowing, heartburn, acid reflux, sore throat, hoarseness, cough, nausea, vomiting, non-cardiac chest pain</description>
        <time_frame>6 months after the procedure</time_frame>
        <population>Patients per group</population>
        <group_list>
          <group group_id="O1">
            <title>Group &quot;20 W / LSI 4&quot;</title>
            <description>Patients elected to atrial fibrillation (AF) ablation and randomized to Combination 1 of radiofrequency energy (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior wall
Combination 1 of radiofrequency energy (RF) power and lesion Size Index (LSI) on LA posterior wall: 20 W RF power and target LSI = 4 on LA posterior wall</description>
          </group>
          <group group_id="O2">
            <title>Group &quot;40 W / LSI 4&quot;</title>
            <description>Patients elected to atrial fibrillation (AF) ablation and randomized to Combination 2 of radiofrequency energy (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior wall
Combination 2 of radiofrequency energy (RF) power and lesion Size Index (LSI) on LA posterior wall: 40 W RF power and target LSI = 4 on LA posterior wall</description>
          </group>
          <group group_id="O3">
            <title>Group &quot;20 W / LSI 5&quot;</title>
            <description>Patients elected to atrial fibrillation (AF) ablation and randomized to Combination 3 of radiofrequency energy (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior wall
Combination 3 of radiofrequency energy (RF) power and lesion Size Index (LSI) on LA posterior wall: 20 W RF power and target LSI = 5 on LA posterior wall</description>
          </group>
          <group group_id="O4">
            <title>Group &quot;40 W / LSI 5&quot;</title>
            <description>Patients elected to atrial fibrillation (AF) ablation and randomized to Combination 4 of radiofrequency energy (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior wall
Combination 4 of radiofrequency energy (RF) power and lesion Size Index (LSI) on LA posterior wall: 40 W RF power and target LSI = 5 on LA posterior wall</description>
          </group>
        </group_list>
        <measure>
          <title>Esophageal Symptoms After the Atrial Fibrillation (AF) Ablation</title>
          <description>Difficult or painful swallowing, heartburn, acid reflux, sore throat, hoarseness, cough, nausea, vomiting, non-cardiac chest pain</description>
          <population>Patients per group</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Procedural Complications</title>
        <description>Pericardial effusion, transient ischemic attack/stroke, phrenic nerve injury, pulmonary vein stenosis, open-heart surgery, death</description>
        <time_frame>1 day</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group &quot;20 W / LSI 4&quot;</title>
            <description>Patients elected to atrial fibrillation (AF) ablation and randomized to Combination 1 of radiofrequency energy (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior wall
Combination 1 of radiofrequency energy (RF) power and lesion Size Index (LSI) on LA posterior wall: 20 W RF power and target LSI = 4 on LA posterior wall</description>
          </group>
          <group group_id="O2">
            <title>Group &quot;40 W / LSI 4&quot;</title>
            <description>Patients elected to atrial fibrillation (AF) ablation and randomized to Combination 2 of radiofrequency energy (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior wall
Combination 2 of radiofrequency energy (RF) power and lesion Size Index (LSI) on LA posterior wall: 40 W RF power and target LSI = 4 on LA posterior wall</description>
          </group>
          <group group_id="O3">
            <title>Group &quot;20 W / LSI 5&quot;</title>
            <description>Patients elected to atrial fibrillation (AF) ablation and randomized to Combination 3 of radiofrequency energy (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior wall
Combination 3 of radiofrequency energy (RF) power and lesion Size Index (LSI) on LA posterior wall: 20 W RF power and target LSI = 5 on LA posterior wall</description>
          </group>
          <group group_id="O4">
            <title>Group &quot;40 W / LSI 5&quot;</title>
            <description>Patients elected to atrial fibrillation (AF) ablation and randomized to Combination 4 of radiofrequency energy (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior wall
Combination 4 of radiofrequency energy (RF) power and lesion Size Index (LSI) on LA posterior wall: 40 W RF power and target LSI = 5 on LA posterior wall</description>
          </group>
        </group_list>
        <measure>
          <title>Procedural Complications</title>
          <description>Pericardial effusion, transient ischemic attack/stroke, phrenic nerve injury, pulmonary vein stenosis, open-heart surgery, death</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 months</time_frame>
      <desc>Regular investigator assessment before discharge after catheter ablation and at subsequent telephone follow-ups</desc>
      <group_list>
        <group group_id="E1">
          <title>Group &quot;20 W / LSI 4&quot;</title>
          <description>Patients elected to AF ablation and randomized to Combination 1 of RF power and LSI on LA posterior wall
Combination 1 of RF power and LSI on LA posterior wall: 20 W RF power and target LSI = 4 on LA posterior wall</description>
        </group>
        <group group_id="E2">
          <title>Group &quot;40 W / LSI 4&quot;</title>
          <description>Patients elected to AF ablation and randomized to Combination 2 of RF power and LSI on LA posterior wall
Combination 2 of RF power and LSI on LA posterior wall: 40 W RF power and target LSI = 4 on LA posterior wall</description>
        </group>
        <group group_id="E3">
          <title>Group &quot;20 W / LSI 5&quot;</title>
          <description>Patients elected to AF ablation and randomized to Combination 3 of RF power and LSI on LA posterior wall
Combination 3 of RF power and LSI on LA posterior wall: 20 W RF power and target LSI = 5 on LA posterior wall</description>
        </group>
        <group group_id="E4">
          <title>Group &quot;40 W / LSI 5&quot;</title>
          <description>Patients elected to AF ablation and randomized to Combination 4 of RF power and LSI on LA posterior wall
Combination 4 of RF power and LSI on LA posterior wall: 40 W RF power and target LSI = 5 on LA posterior wall</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="20"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Pericardial effusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Stroke</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Milena Leo</name_or_title>
      <organization>John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust</organization>
      <phone>0186522055</phone>
      <email>milena.leo@ouh.nhs.uk</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

